Filing Details
- Accession Number:
- 0001209191-20-007474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-07 16:07:57
- Reporting Period:
- 2020-02-05
- Accepted Time:
- 2020-02-07 16:07:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 2,526 shares | Avg. Price: $239.42 | Total Value: $604,774.76 |
| Number of Shares After Transactions: | 70,310 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-05 | 18,204 | $0.00 | 49,757 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-02-05 | 8,166 | $0.00 | 57,923 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-02-05 | 12,387 | $0.00 | 70,310 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-02-06 | 1,303 | $187.53 | 71,613 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-06 | 1,223 | $155.57 | 72,836 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-06 | 1,462 | $238.74 | 71,374 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 630 | $239.63 | 70,744 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 280 | $240.82 | 70,464 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 154 | $242.47 | 70,310 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-06 | 1,303 | $0.00 | 1,303 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-06 | 1,223 | $0.00 | 1,223 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,642 | 2029-02-05 | No | 4 | M | Direct | |
| 9,783 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020.
- Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 02/24/2020.
- Restricted stock unit award that vests in installments beginning on 02/10/2021.
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $238.74 (range $238.16 to $239.14).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $239.63 (range $239.22 to $240.04).
- Open market sales reported on this line occurred at a weighted average price of $240.82 (range $240.60 to $241.04).
- The option vests in 16 quarterly installments from 02/06/2019.
- The option vests in 16 quarterly installments from 02/06/2018.
Billionaire Hedge Funds
